Jazz Pharmaceuticals PLC (JAZZ) Q2 2025 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Jack Spinks — Investor Relations Bruce Cozadd — Chief Executive…
8 articles, transcripts, and reports
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Jack Spinks — Investor Relations Bruce Cozadd — Chief Executive…
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q3 2025 Earnings Call dated Nov. 05, 2025 Corporate Participants: Jack Spinks — Executive Director, Investor Relations Renee Gala —…
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Andrea Flynn — Vice President and Head, Investor Relations Bruce C. Cozadd — Chairman and…
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox — Executive Director, Investor Relations Bruce C. Cozadd — Chairman and Chief Executive…
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Andrea N. Flynn — Vice President, Head, Investor Relations Bruce C. Cozadd — Chairman and…
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Andrea N. Flynn — Vice President, Head, Investor Relations Bruce C. Cozadd — Chairman…
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Andrea N. Flynn — Vice President and Head of Investor Relations Bruce…
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q4 2020 earnings call dated Feb. 23, 2021 Corporate Participants: Andrea N. Flynn — Vice President, Head of Investor Relations Bruce C.…